Publications by authors named "Sherry Ku"

Claim this Profile
A
A biopharmaceutical classification-based Right-First-Time formulation approach to reduce human pharmacokinetic variability and project cycle time from First-In-Human to clinical Proof-Of-Concept.
M Sherry Ku, Wendy Dulin

Pharm Dev Technol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 2: comparative assessment of prediction methods of human volume of distribution.
Rhys Do Jones, Hannah M Jones, Malcolm Rowland, Christopher R Gibson, James W T Yates, M Sherry Ku

J Pharm Sci· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 4: prediction of plasma concentration-time profiles in human from in vivo preclinical data by using the Wajima approach.
Ragini Vuppugalla, Punit Marathe, Handan He, Rhys D O Jones, James W T Yates, M Sherry Ku

J Pharm Sci· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 1: goals, properties of the PhRMA dataset, and comparison with literature datasets.
Patrick Poulin, Hannah M Jones, Rhys Do Jones, James W T Yates, Christopher R Gibson, M Sherry Ku

J Pharm Sci· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PHRMA CPCDC initiative on predictive models of human pharmacokinetics, part 5: prediction of plasma concentration-time profiles in human by using the physiologically-based pharmacokinetic modeling approach.
Patrick Poulin, Rhys D O Jones, Hannah M Jones, Christopher R Gibson, Malcolm Rowland, M Sherry Ku

J Pharm Sci· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: comparative assessement of prediction methods of human clearance.
Barbara J Ring, Jenny Y Chien, Kimberly K Adkison, Hannah M Jones, Malcolm Rowland, M Sherry Ku

J Pharm Sci· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance qualification of a new hypromellose capsule: Part II. Disintegration and dissolution comparison between two types of hypromellose capsules.
M Sherry Ku, Qinghong Lu, Weiyi Li, Yansong Chen

Int J Pharm· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asymmetry effect of particle size distribution on content uniformity and over-potency risk in low-dose solid drugs.
Chien-Yueh Huang, M Sherry Ku

J Pharm Sci· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Solid dispersion of acetaminophen and poly(ethylene oxide) prepared by hot-melt mixing.
Min Yang, Peng Wang, Chien-Yueh Huang, M Sherry Ku, Huiju Liu

Int J Pharm· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance qualification of a new hypromellose capsule: part I. Comparative evaluation of physical, mechanical and processability quality attributes of Vcaps Plus, Quali-V and gelatin capsules.
M Sherry Ku, Weiyi Li, Wendy Dulin, Fran Donahue, Dominique Cade

Int J Pharm· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of drug particle size and content uniformity in low-dose solid dosage forms.
Chien-Yueh Huang, M Sherry Ku

Int J Pharm· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of the Biopharmaceutical Classification System in early drug development.
M Sherry Ku

AAPS J· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indole cytosolic phospholipase A2 alpha inhibitors: discovery and in vitro and in vivo characterization of 4-{3-[5-chloro-2-(2-{[(3,4-dichlorobenzyl)sulfonyl]amino}ethyl)-1-(diphenylmethyl)-1H-indol-3-yl]propyl}benzoic acid, efipladib.
John C McKew, Katherine L Lee, Marina W H Shen, Paresh Thakker, Megan A Foley, Kun Wu, M Sherry Ku

J Med Chem· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Ecopladib, an indole inhibitor of cytosolic phospholipase A2alpha.
Katherine L Lee, Megan A Foley, Lihren Chen, Mark L Behnke, Frank E Lovering, M Sherry Ku

J Med Chem· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral bioavailability of pantoprazole suspended in sodium bicarbonate solution.
Geraldine M Ferron, Sherry Ku, Madelyn Abell, Mary Unruh, John Getsy

Am J Health Syst Pharm· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis